Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Clinical trial NCT00258960 · COMPLETED
Trial details
- NCT number
- NCT00258960
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-15
- Primary completion
- 2008-07-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.